Fevipiprant-13CD3 is the labeled version of F321755.
Fevipiprant is used in the oral treatment of asthma and has been successful in targeting severe eosinophilic asthma.
Fevipiprant is a novel oral prostaglandin D2 receptor 2 (DP2; known as CRTh2) antagonist and currently in development for the treatment of severe asthma and atopic dermatitis.
Molecular Formula
C1813CH14D3F3N2O4S
Storage and Stability
Store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.